Klinik und Poliklinik für Urologie und Kinderurologie
Klinikum / Johannes Gutenberg-Universität Mainz
Raven, Peter A.; D'Costa, Ninadh M.; Moskalev, Igor et al.
Development of a murine intravesical orthotropic human bladder cancer (mio-hBC) modelAMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY. Bd. 6. H. 6. 2018 S. 245-259
Haferkamp, A.
Diagnosis and Treatment of small Renal MassesUROLOGE. Bd. 57. H. 3. 2018 S. 272-272
Thomas, Christian; Brandt, Maximilian P.; Baldauf, Stephanie et al.
Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survivalINTERNATIONAL UROLOGY AND NEPHROLOGY. Bd. 50. H. 10. 2018 S. 1821-1827
An, Julie Y.; Harmon, Stephanie A.; Mehralivand, Sherif et al.
Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15mm the best threshold?ABDOMINAL RADIOLOGY. Bd. 43. H. 12. 2018 S. 3436-3444
Marra, Giancarlo; Ploussard, Guillaume; Ost, Piet et al.
Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European surveyUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. Bd. 36. H. 12. 2018
Guggenberger, Fabian; van de Werken, Harmen J. G.; Erb, Holger H. H. et al.
Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint SignaturesEUROPEAN UROLOGY. Bd. 74. H. 6. 2018 S. 847-849
Boehm, Katharina; Thomas, Christian; Tsaur, Igor
Genetic profiling in the diagnosis of hereditary prostate cancer: Where dowe stand?AKTUELLE UROLOGIE. Bd. 49. H. 6. 2018 S. 525-529
Wenzel, M.; Salem, J.; Borgmann, H.
GeSRU Academics: Network for Young Academic Urologists - Update 2018UROLOGE. Bd. 57. H. 4. 2018 S. 513-515
Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva et al.
HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR SuppressionCELLS. Bd. 7. H. 9. 2018
Gandaglia, Giorgio; van den Bergh, Roderick C. N.; Tilki, Derya et al.
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculatorBJU INTERNATIONAL. Bd. 122. H. 5. 2018 S. 823-830